Go back to Resource Center
Evaluation of intravenous immunoglobulin (IVIG) as an agent to lower allosensitization and improve transplantation in highly-sensitized adult ESRD patients: report of the NIH IG02 trial
2004
Journal Article
Authors:
Jordan, S.C.;
Tyan, D.;
Stablein, D.;
McIntosh, M.;
Rose, S.;
Vo, A.;
Toyoda, M.;
Davis, C.;
Shapiro, R.;
Adey, D.;
Milliner, D.;
Graff, R.;
Steiner, R.;
Ciancio, G.;
Sahney, S.;
Light, J.
Secondary:
J Am Soc Nephrol
Pagination:
3256-3262
